Zeinab Mohseni Afshar

Zeinab Mohseni Afshar

Auto-generated profile, based on publicly available information

Zeinab Mohseni Afshar

Infectious Diseases and Tropical Medicine Research Center, Health Research Institute Babol University of Medical Sciences Babol Iran

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 October 2021 in Reviews in Medical Virology
Verified
Journal Article
Open access
PDF file
ZAZeinab Mohseni Afshar
Zeinab Mohseni Afshar
ABArefeh Babazadeh
Arefeh Babazadeh
AJAlireza Janbakhsh
Alireza Janbakhsh
FMFeizollah Mansouri
Feizollah Mansouri
TSTerence T. Sio
Terence T. Sio
Soheil EbrahimpourSoheil Ebrahimpour
Soheil Ebrahimpour
Summary: Vaccination against severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is a crucial step in ending the current worldwide pandemic. However, several particularly vulnerable groups in the population were not included in sufficient numbers in coronavirus disease 2019 (Covid‐19) vaccine trials. Therefore, as science advances, the advice for vaccinating these special populations against Covid‐19 will continue to evolve. This focused review provides the latest recommendations and considerations for these special populations (i.e., patients with rheumatologic and autoimmune disorders, cancer, transplant recipients, chronic liver diseases, end‐stage renal disease, neurologic disorders, psychiatric disorders, diabetes mellitus, obesity, cardiovascular diseases, chronic obstructive pulmonary disease, human immunodeficiency virus, current smokers, pregnant and breastfeeding women, the elderly, children, and patients with allergic reactions) using the currently available research evidence.

1 July 2021 in Reviews in Medical Virology
Verified
Journal Article
Open access
PDF file
ZAZeinab Mohseni Afshar
Zeinab Mohseni Afshar
ABArefeh Babazadeh
Arefeh Babazadeh
AJAlireza Janbakhsh
Alireza Janbakhsh
MAMandana Afsharian
Mandana Afsharian
Kiarash SalekiKiarash Saleki
Kiarash Saleki
Soheil EbrahimpourSoheil Ebrahimpour
Soheil Ebrahimpour
Summary: The coronavirus disease 2019 (Covid‐19) pandemic has had devastating effects on public health worldwide, but the deployment of vaccines for Covid‐19 protection has helped control the spread of SARS Coronavirus 2 (SARS‐CoV‐2) infection where they are available. The common side effects reported following Covid‐19 vaccination were mostly self‐restricted local reactions that resolved quickly. Nevertheless, rare vaccine‐induced immune thrombotic thrombocytopenia (VITT) cases have been reported in some people being vaccinated against Covid‐19. This review summarizes the thromboembolic events after Covid‐19 vaccination and discusses its molecular mechanism, incidence rate, clinical manifestations and differential diagnosis. Then, a step‐by‐step algorithm for diagnosing such events, along with a management plan, are presented. In conclusion, considering the likeliness of acquiring severe SARS‐CoV‐2 infection and its subsequent morbidity and mortality, the benefits of vaccination outweigh its risks. Hence, if not already initiated, all governments should begin an effective and fast public vaccination plan to overcome this pandemic.

16 July 2021 in Journal of Medical Virology
Verified
Journal Article
Open access
PDF file
ZAZeinab Mohseni Afshar
Zeinab Mohseni Afshar
ABArefeh Babazadeh
Arefeh Babazadeh
AHAmirhossein Hasanpour
Amirhossein Hasanpour
MBMohammad Barary
Mohammad Barary
BSBabak Sayad
Babak Sayad
Soheil EbrahimpourSoheil Ebrahimpour
Soheil Ebrahimpour
Coronavirus disease 2019 (COVID‐19) caused by severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) has become a significant health problem globally. The virus has spread widely and become a global pandemic. The pathophysiology for SARS‐CoV‐2 has not been explained clearly. It has been associated with several multiorgan symptoms, among which its dermatological manifestations are of great interest. Primarily, there has been no report of skin features among COVID‐19 patients. Nevertheless, recently there have been several reports regarding COVID‐19 patients who presented with cutaneous manifestations. In the current review, we focus on the various cutaneous manifestations of COVID‐19 infection.


23 December 2021 in Cancer Medicine
Verified
Journal Article
Open access
PDF file
ZAZeinab Mohseni Afshar
Zeinab Mohseni Afshar
RHRezvan Hosseinzadeh
Rezvan Hosseinzadeh
MBMohammad Barary
Mohammad Barary
Soheil EbrahimpourSoheil Ebrahimpour
Soheil Ebrahimpour
AAAmirmasoud Alijanpourotaghsara
Amirmasoud Alijanpourotaghsara
ABArefeh Babazadeh
Arefeh Babazadeh
A novel coronavirus, or severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), was identified as the causative agent of coronavirus disease 2019 (COVID‐19). In early 2020, the World Health Organization declared COVID‐19 the sixth public health emergency of international concern. The COVID‐19 pandemic has substantially affected many groups within the general population, but particularly those with extant clinical conditions, such as having or being treated for cancer. Cancer patients are at a higher risk of developing severe COVID‐19 since the malignancy and chemotherapy may negatively affect the immune system, and their immunocompromised condition also increases the risk of infection. Substantial international efforts are currently underway to develop specific methods for diagnosing and treating COVID‐19. However, cancer patients’ risk profiles, management, and outcomes are not well understood. Thus, the main objective of this review is to discuss the relevant evidence to understand the prognosis of COVID‐19 infections in cancer patients more clearly, as well as helping to improve the clinical management of these patients.

10 June 2022 in Journal of Prevention
Verified
Journal Article
Closed access
PDF file
MKMohsen Kazeminia
Mohsen Kazeminia
ZAZeinab Mohseni Afshar
Zeinab Mohseni Afshar
MRMojgan Rajati
Mojgan Rajati
ASAnahita Saeedi
Anahita Saeedi
FRFatemeh Rajati
Fatemeh Rajati